[Skip to Content]
[Skip to Content Landing]
Views 2,009
Citations 0
News From the Food and Drug Administration
February 18, 2020

FDA Assesses Potential Cancer Risk Associated With Weight Loss Drug

JAMA. 2020;323(7):600. doi:10.1001/jama.2020.0834

A recent drug safety communication alerted health professionals and the public about a potential increased risk of cancer associated with the weight management medication lorcaserin. The FDA has advised clinicians to consider whether the drug’s benefits outweigh its potential risks when deciding to prescribe or continue prescribing it.